Lazard Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
IA
BTI
CFB
HNB
Lazard Asset Management's SYNH Position: Q3 2023 in Review
Lazard Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 6,185 shares — an estimated $260K sold.
Lazard Asset Management first reported a position in SYNH in Q3 2015 and held it in 15 quarters. The position peaked at $43.7M in Q2 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Lazard Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Lazard Asset Management sold 6,185 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $260K.
- Lazard Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 15 quarters.
- Lazard Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $43.7M in Q2 2017.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.